BioLargo Inc (OTCPK:BLGO)
$ 0.095 +0.0014 (+1.44%) Market Cap: 31.18 Mil Enterprise Value: 34.51 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q3 2025 BioLargo Inc Earnings Call Transcript

Nov 14, 2025 / 09:30 PM GMT
Release Date Price: $0.15653 (-7.87%)

Key Points

Positve
  • BioLargo Inc (BLGO) is seeing significant progress in its portfolio, with several assets nearing commercialization, including its antimicrobial products and energy tech solutions.
  • The company has a strong focus on sustainability and human health, driven by purpose and innovation, which positions it well in transformative markets.
  • BioLargo Inc (BLGO) has successfully raised capital at favorable valuations, indicating investor confidence in its assets, such as the $44 million valuation for its battery technology.
  • The company has established strategic partnerships, such as with Advanced Solutions for wound care products, which are expected to generate meaningful revenues.
  • BioLargo Inc (BLGO) has a diversified portfolio that minimizes risk and leverages highly qualified staff, including 10-12 PhDs and 30 engineers, to drive innovation and market adoption.
Negative
  • The company is facing significant challenges with its 'Poof' product, including a lawsuit and a $3.85 million credit loss, impacting its financial performance.
  • BioLargo Inc (BLGO) has experienced delays in business developments, such as the Lake Stockholm project and the commercialization of its medical products, causing investor frustration.
  • The company's market cap is significantly lower than its perceived value, trading around $50 million despite arguments for a $200 million valuation, leading to management and stockholder frustration.
  • BioLargo Inc (BLGO) is operating in a highly competitive and rapidly evolving market, which requires continuous innovation and adaptation to maintain its competitive edge.
  • The company is still in the early stages of commercialization for many of its technologies, which means it has yet to generate significant revenue from these assets.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BLGO.PK - BioLargo Inc
Q3 2025 BioLargo Inc Earnings Call
Nov 14, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day everyone. Welcome to the Vio Lago Q3 earnings results conference call. At this time, all participants have been placed on a listen-only mode. It is now my pleasure to turn the floor over to your host, Brian Loper. The floor is yours.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Great, thank you very much. Good afternoon, everybody, and welcome to this quarterly conference call for the month ended September 30th, 2025. This call is being webcast and is available for replay. In our remarks today, we will include statements that are considered forward-looking within the meanings of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot